not logged in
Reports
Myeloma Patients Europe (MPE) has developed educational reports on myeloma for patients, advocates and organisations. Through these, we aim to address the most pressing access topics for the patient community and support advocates in their work to improve patient outcomes.
You can find our current reports below:
Addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE). The report, led by the MPE Central and Eastern Europe (CEE) Workgroup on Access, found huge inequalities for patients, confirming reports from MPE CEE members about a lack of clinical trials opening in the region and difficulties in patient participation.
“Assessment of quality of life data in myeloma clinical trials between 2011 and 2021″. To understand how Quality of Life (QoL) and Health-Related Quality of Life (HRQoL) are currently being measured in myeloma, MPE and Consilium Scientific undertook research to analyse registered myeloma clinical trials and published literature between 2011 and 2021.
